CTXR CITIUS PHARMACEUTICALS INC: institutional ownership and insider trading
43 funds reported holding $960K of CITIUS PHARMACEUTICALS INC in their latest 13F filings; in Q2 2026 funds net bought $187K, with 11 new positions and 8 funds selling out.
Famous investors holding CTXR
- Ken Griffin (Citadel Advisors): $75.5K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $10.6K, 0.0% of the portfolio
Largest institutional holders of CTXR
- VANGUARD GROUP INC — $155K
- GEODE CAPITAL MANAGEMENT, LLC — $130K
- VANGUARD CAPITAL MANAGEMENT LLC — $119K
- Miller Financial Services LLC — $81.8K
- CITADEL ADVISORS LLC — $75.5K
- JANE STREET GROUP, LLC — $74.3K
- VANGUARD FIDUCIARY TRUST CO — $47.0K
- BlackRock, Inc. (BLK) — $42.2K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $37.9K
- XTX Topco Ltd — $35.8K
5%+ owners
- CVI Investments, Inc.: 9.9% (Schedule 13G/A, filed Aug 14, 2026)
Who owns the most CTXR stock?
The largest institutional holders of CITIUS PHARMACEUTICALS INC in the latest 13F filings are VANGUARD GROUP INC ($155K), GEODE CAPITAL MANAGEMENT, LLC ($130K), VANGUARD CAPITAL MANAGEMENT LLC ($119K).
Which famous investors own CTXR?
Ken Griffin, Two Sigma.